FDA: MS Drug Linked To Cases of Cervicocephalic Arterial Dissection

The FDA has issued a warning regarding rare cases of ischemic and hemorrhagic stroke and cervicocephalic arterial dissection in patients with MS shortly after receiving Lemtrada.

Source link

Related posts

hayden’s heart + Fin First = hayden’s dream


New protein ‘regenerates’ the heart after an attack


Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy